Cefotaxime and ceftazidime were used as the initial screening standards, and strains resistant to both cefotaxime and ceftazidime were selected for ESBL screening. The double-disk synergy method was designed for drug susceptibility testing. ESBLs have the property of being inhibited by clavulanate. Bacteriostatic rings were found in resistant strains around the mixed discs of third-generation cephalosporins and clavulanate. If clavulanate increased the bacteriostatic ring by more than 5 mm, the isolates were presumed to produce ESBLs. Escherichia coli (ATCC 25922) and Klebsiella quasipneumoniae (ATCC 700603) were used as negative and positive controls, respectively.
Free full text: Click here